Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2023

Month: March

Request Number: A-2018-001598

Request Summary: Module 1 along with the reviewers note of the INTELLI-SEVELAMER 800 MG tablets New Drug Submission (NDS) Control No: 222726 - DIN 02484110 for INTELLIPHARM INC.

Disposition: Disclosed in part

Number of pages: 111

Date modified: